Takeda Pharmaceutical Co Ltd

Investment Portfolio & 13F Holdings Analysis

About

TAKEDA PHARMACEUTICAL CO LTD is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 11 holdings worth $0.0 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-12
Total Holdings: 11
Total Value: 14400016
Accession Number: 0001395064-25-000055
Form Type: 13F-HR
CIK: 0001395064
Manager Name: Takeda Pharmaceutical Co Ltd

Data Enrichment

100% identified

11 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

11 positions • $14,400.016K total value

11 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Sort by:

HilleVax, Inc.

HLVX|43157M102

6724000(+0.0%)

Value:

$9.8B(-29.9%)

Xilio Therapeutics, Inc.

XLO|98422T100

1475121(+0.0%)

Value:

$1.1B(-24.6%)

Equillium, Inc.

EQ|29446K106

1824977(+0.0%)

Value:

$711.7M(-48.0%)

American Well Corp

AMWL|03044L204

77733(+0.0%)

Value:

$612.5M(+8.7%)

Ovid Therapeutics Inc.

OVID|690469101

1781996(+0.0%)

Value:

$555.8M(-66.6%)

Shattuck Labs, Inc.

STTK|82024L103

515619(+0.0%)

Value:

$489.8M(-21.5%)

Lyell Immunopharma, Inc.

LYEL|55083R104

823317(+0.0%)

Value:

$442.9M(-15.9%)

Turnstone Biologics Corp.

TSBX|90042W100

895824(+0.0%)

Value:

$367.3M(-18.0%)

Rani Therapeutics Holdings, Inc.

RANI|753018100

203190(+0.0%)

Value:

$256.0M(-8.0%)

Third Harmonic Bio, Inc.

THRD|88427A107

36835(+0.0%)

Value:

$127.8M(-66.3%)

STANDARD BIOTOOLS INC.

LAB|34385P108

16515(+0.0%)

Value:

$17.8M(-38.3%)

Instrument	Shares		Other Manager	Value
Hillevax, Inc.(HLVXcusip43157M102)	6.7M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$9.8M	QoQ -29.94% (-$4.2M) YoY -91.28% (-$102.1M)
Xilio Therapeutics, Inc.(XLOcusip98422T100)	1.5M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.1M	QoQ -24.58% (-$348.1K) YoY -32.96% (-$525.1K)
Equillium, Inc.(EQcusip29446K106)	1.8M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$711.7K	QoQ -48.00% (-$657.0K) YoY -83.11% (-$3.5M)
American Well Corp(AMWLcusip03044L204)	77.7K	QoQ 0.00% (+0) YoY -95.00% (-1.5M)	All Managers (Combined)	$612.5K	QoQ +8.69% (+$49.0K) YoY -51.40% (-$647.8K)
Ovid Therapeutics Inc.(OVIDcusip690469101)	1.8M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$555.8K	QoQ -66.60% (-$1.1M) YoY -89.77% (-$4.9M)
Shattuck Labs, Inc.(STTKcusip82024L103)	515.6K	QoQ 0.00% (-0) YoY -65.64% (-985.4K)	All Managers (Combined)	$489.8K	QoQ -21.48% (-$134.1K) YoY -96.34% (-$12.9M)
Lyell Immunopharma, Inc.(LYELcusip55083R104)	823.3K	QoQ 0.00% (-0) YoY NEW(+823.3K)	All Managers (Combined)	$442.9K	QoQ -15.93% (-$84.0K) YoY NEW(+$442.9K)
Turnstone Biologics Corp.(TSBXcusip90042W100)	895.8K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$367.3K	QoQ -17.99% (-$80.6K) YoY -84.35% (-$2.0M)
Rani Therapeutics Holdings, Inc.(RANIcusip753018100)	203.2K	QoQ 0.00% (-0) YoY -40.00% (-135.5K)	All Managers (Combined)	$256.0K	QoQ -8.02% (-$22.4K) YoY -75.69% (-$797.3K)
Third Harmonic Bio, Inc.(THRDcusip88427A107)	36.8K	QoQ 0.00% (-0) YoY NEW(+36.8K)	All Managers (Combined)	$127.8K	QoQ -66.27% (-$251.2K) YoY NEW(+$127.8K)
Standard Biotools Inc.(LABcusip34385P108)	16.5K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$17.8K	QoQ -38.28% (-$11.1K) YoY -60.14% (-$26.9K)